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ABSTRACT
For a very long time, Type II restriction enzymes
(REases) have been a paradigm of ORFans: proteins
with no detectable similarity to each other and to any
other protein in the database, despite common
cellular and biochemical function. Crystallographic
analyses published until January 2008 provided
high-resolution structures for only 28 of 1637
Type II REase sequences available in the Restriction
Enzyme database (REBASE). Among these struc-
tures, all but two possess catalytic domains with the
common PD-(D/E)XK nuclease fold. Two structures
are unrelated to the others: R.BfiI exhibits the phos-
pholipase D (PLD) fold, while R.PabI has a new fold
termed ‘half-pipe’. Thus far, bioinformatic studies
supported by site-directed mutagenesis have
extended the number of tentatively assigned REase
folds to five (now including also GIY-YIG and HNH
folds identified earlier in homing endonucleases) and
provided structural predictions for dozens of REase
sequences without experimentally solved struc-
tures. Here, we present a comprehensive study of
all Type II REase sequences available in REBASE
together with their homologs detectable in the non-
redundant and environmental samples databases
at the NCBI. We present the summary and critical
evaluation of structural assignments and predictions
reported earlier, new classification of all REase
sequences into families, domain architecture anal-
ysis and new predictions of three-dimensional folds.
Among 289 experimentally characterized (not puta-
tive) Type II REases, whose apparently full-length
sequences are available in REBASE, we assign
199 (69%) to contain the PD-(D/E)XK domain.
The HNH domain is the second most common,
with 24 (8%) members. When putative REases are
taken into account, the fraction of PD-(D/E)XK and
HNH folds changes to 48% and 30%, respectively.
Fifty-six characterized (and 521 predicted) REases
remain unassigned to any of the five REase folds
identified so far, and may exhibit new architectures.
These enzymes are proposed as the most interesting
targets for structure determination by high-resolu-
tion experimental methods. Our analysis provides
the first comprehensive map of sequence-structure
relationships among Type II REases and will help to
focus the efforts of structural and functional geno-
mics of this large and biotechnologically important
class of enzymes.
INTRODUCTION
Type II restriction endonucleases (REases) are enzymes
that recognize short DNA sequences (usually 4–8-bp long)
and cleave the target in both strands at, or in close
proximity to the recognition site. Orthodox REases are
homodimeric, cleave within palindromic sequences,
require Mg
2+ ions and can act on single copies of their
targets. Type II enzymes that exhibit structural and func-
tional peculiarities (requirement of more than one target
site for cleavage, cleavage at a distance from the asym-
metrical target, etc.) have been classiﬁed into subtypes
[nomenclature reviewed in ref. (1)]. Because of remarkably
high speciﬁcity in recognizing and cleaving their target
sequences, they are of high interest as model systems for
analyzing protein-DNA interactions and one of the most
frequently used tools for recombinant DNA technology
[most recent reviews: (2,3), a comprehensive collection of
reviews on REases has been also published as a book (4)].
In nature, Type II REases are found in prokaryotic
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Modiﬁcation (RM) systems with DNA methyltransferases
(MTases) of the same or very similar substrate speciﬁcity.
DNA MTases use S-adenosylmethionine (AdoMet) as a
methyl group donor to modify speciﬁc bases in the target
sequence, thereby rendering it resistant to cleavage by the
REase. Thus, while the RM system’s own DNA (together
with the whole DNA of the prokaryotic host) is protected
against suicidal degradation by REase, any foreign DNA
that invades the host cell and lacks protective methylation
(e.g. phages, plasmids, etc.), may be eﬃciently destroyed
(5). In order to distinguish the components of RM system
the names of MTase and REase are preceded with ‘M’. and
‘R.’ preﬁxes, respectively, (e.g. M.FokI and R.FokI).
Type II REases have a very high speciﬁcity and simple
substrate requirements, which makes them very popular as
tools in biotechnology. There are other classes of REases
(Types I, III and IV), multisubunit and complex molecular
machines that may combine multiple activities including
restriction, methylation and DNA translocation, require
additional cofactors (e.g. AdoMet, ATP or GTP), bind
more than one target site, and cleave outside the recog-
nition sequence, often at a random distance. Comparative
analysis of these enzymes is outside the scope of this
article, the reader is referred to recent review articles for a
survey and summary of their functional properties (4,6,7).
A wealth of information about all REases, including
sequences, structures and functional annotations, is stored
in a dedicated database REBASE (8).
Since the ﬁrst genes encoding Type II REases were
cloned and sequenced, comparisons have been made,
aimed at detecting similarities indicative of common
evolutionary history and/or mechanism of action (9–11).
Surprisingly, these analyses revealed very little sequence
similarity, usually limited to groups of isoschizomers, i.e.
enzymes that exhibit identical DNA recognition sites and
cleavage speciﬁcities (11,12). Database searches with
REase sequences typically revealed either no signiﬁcant
similarity to any protein, or very high similarity (often
>90% identity) to a few isoschizomers, and no similarity
to other proteins. This strongly biased distribution of
similarities and dissimilarity made comparative sequence
analysis of all REases impossible with the use of standard
tools for sequence alignment and raised a question whether
the diversity of amino acid sequences of REases indicates
polyphyletic evolution (convergence) or extreme diver-
gence from a common ancestor (5,13).
The ﬁrst answer to the question whether or not REases
are related to each other was provided by crystallographic
analyses. Already the ﬁrst two structures of REases
with apparently dissimilar sequences [R.EcoRI (14) and
R.EcoRV (15)] revealed a common three-dimensional fold
and similar active sites (16), which indicates that they
are evolutionarily related and that the overall sequence
dissimilarity is due to divergent evolution (homology)
rather than convergence (analogy). Essentially the same
features were repeatedly observed in all crystal structures
of Type II REases, at least until 2005, and in many other
nucleases involved in a variety of cellular processes,
e.g. DNA repair enzyme MutH or Holliday junction
resolvases (17,18). Catalytic domains of these proteins
share a common structural core, comprising a mixed
b-sheet of 4 strands ﬂanked on both sides by a-helices
and additional, variable elements of secondary structure
(16,19–21). The core serves as a scaﬀold for a weakly
conserved active site, typically comprising two or three
acidic residues (Asp or Glu) and one Lys residue, which
together form the hallmark bipartite catalytic motif
(P)D...Xn...(D/E)XK (where X is any amino acid). This
motif has led to naming this superfamily of proteins as
‘PD-(D/E)XK’ (22,23).
It was found that some members of the PD-(D/E)XK
superfamily exhibit deviations from the consensus. First,
the active sites of Type II REases often contain non-
standard residues at the otherwise conserved positions,
e.g. Q or N at the positions occupied by the (D/E)XK
half-motif (24,25). Second, catalytic residues have been
also found to ‘migrate’ between nonequivalent positions in
sequence, preserving the spatial orientation of functional
groups in the active site without the correspondence at
the level of the sequence alignment (26–28). These two
features have been also reported in some non-REase
members of the PD-(D/E)XK superfamily (23,29,30), but
when combined with the extreme overall sequence diver-
gence characteristic for REases, they essentially prevent
the identiﬁcation of an active site by ‘sequence gazing’.
As a result, sequence–function analysis usually requires
the aid of three-dimensional structure (ideally—solved
experimentally, or obtained by comparative modeling
techniques).
Type II REases are notorious for presenting elabora-
tions of the common fold in the form of large insertions
and terminal extensions that often contain regular
elements of secondary structure, even entire domains.
These elaborations form a variable ‘shell’ surrounding the
conserved core and are often involved in DNA binding or
formation of contacts between protomers in oligomeric
structures. They may be responsible for the formation
of completely diﬀerent quaternary structures even by
enzymes that are very similar at the level of tertiary
structure, e.g. R.EcoRV and R.BglI (31). In a phylogenetic
tree of PD-(D/E)XK enzymes with known structures,
Type II REases radiate from all major branches of the
superfamily, indicating multiple independent recruitment
of the same fold to the process of restriction. The accu-
mulation of a large number of changes suggests higher
speed of evolution associated with being involved in
restriction, compared to other PD-(D/E)XK enzymes
involved in house-keeping processes such as DNA repair
(20). Type II REases are therefore extremely hard targets
for protein structure prediction methods, and even detec-
tion of the PD-(D/E)XK motif in their sequence remains a
formidable challenge (20,32).
Not all REases, however, are members of the PD-(D/E)
XK superfamily. In 2000, three groups discovered a
few REases that appeared to be members of structurally
and evolutionarily unrelated superfamilies: Siksnys and
co-workers discovered that R.BﬁI belongs to the phos-
pholipase D (PLD) superfamily (33), the group of Koonin
and independently one of the authors of this article
(J.M.B.) predicted that a few REases belong to the HNH
superfamily (34,35); J.M.B. also predicted that R.Eco29kI
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the GIY-YIG superfamily (35). Since then, all these
theoretical predictions have been conﬁrmed experimen-
tally. The structure of R.BﬁI has been solved, revealing
a PLD-like dimer of catalytic domains with a single
symmetrical active site at the domain interface (36).
Structural models of HNH nuclease domain in R.KpnI
(37) and GIY-YIG nuclease domain in R.Eco29kI (38)
have been supported by mutagenesis and biochemical
experiments. Most recently, a newly identiﬁed REase
R.PabI was predicted to be a candidate for a new fold
(39), which has been validated by X-ray crystallography
and mutagenesis, revealing a novel tertiary and quater-
nary architecture (40). It must be mentioned that two of
these nonstandard enzymes (R.BﬁI and R.PabI) exhibit
a feature that may be even more unusual than their
nonclassical folds: they cleave DNA in the absence of
metal ions (33,40). Thus, structurally characterized Type
II REases present ﬁve unrelated three-dimensional folds,
several diﬀerent variants of active sites and catalytic
mechanisms, and a plethora of modes for protein–protein
and protein–DNA interactions.
REBASE, the database of restriction enzymes makes
available to the public (as of 25 January 2008) 1637
sequences of Type II REases, including 302 experimentally
characterized enzymes and 1335 putative ones, inferred
from sequence comparisons or genomic analyses. Many
REase candidates are ORFans, i.e. proteins that show no
similarity to any other protein (or only very high similarity
to a few other proteins). Some of them have been
predicted only because they are encoded by genes located
close to genes encoding true or predicted DNA MTases.
The disproportion between the number of known or
predicted sequences and the number of experimentally
characterized proteins with known three-dimensional
structures (>50 to 1) is similar to the average value
reported for sequences inferred from genome sequencing
projects. Thus, Type II REases can be regarded as a ‘ﬁring
range’ for structural genomics projects in a sense that any
methodology (theoretical or experimental) developed to
narrow down this gap may be broadly applicable to all
proteins. Some eﬀorts have been made in this direction.
Bioinformatics analyses have been made to assign a
fraction of REase sequences to the previously identiﬁed
folds (22,23,34,35,41) and site-directed mutagenesis has
been used, often in connection with the circular dichroism
(CD) analysis, to test some of these predictions [e.g.
(27,42–49)]. Because of the diﬃculties in predicting
variable regions, most of the published alignments and
models contain only the catalytic domain, or just the
immediate neighborhood of the active site. Nonetheless,
these predictions, especially if supported by experimental
data, are usually suﬃcient to provide a conﬁdent three-
dimensional fold assignment (which implies evolutionary
relationship to other members), and provide numerous
additional hints regarding the possible mechanism of
action (e.g. the mode of DNA binding).
Bioinformatic and low-resolution experimental analyses
have aided X-ray crystallography in assigning a number
of Type II REases to known folds and superfamilies.
However, a large fraction of REases remains without any
predictions or experimental data. Moreover, there is no
single resource a researcher could use, that indicates
whether any structural or evolutionary prediction has
been made for a given REase sequence, what the assigned
fold is, where the structural model is available, and
whether any experimental data support the theoretical
analyses. Currently, navigation in a large volume of data
and literature concerning diﬀerent REase structures and
families is very diﬃcult not only for newcomers in the
REase ﬁeld, but also for biochemists, who are not
necessarily experts in molecular evolution or structural
bioinformatics, but would like to take the advantage of
published predictions to plan new experiments. We have
therefore decided to survey the published literature and
databases for experimental data and predictions concern-
ing the structure of all Type II REases with sequences
available in REBASE, and to make new predictions for
the great majority that had no such information available.
We carried out a search for additional homologs of Type
II REases, not yet available in REBASE, and clustered all
sequences to identify groups of close homologs that are
likely to share very similar structures as well as substrate
speciﬁcities (isoschizomers or nearly-isoschizomers). As a
result, we provide the very ﬁrst classiﬁcation of all Type II
REase sequences into families and superfamilies, and
a comprehensive structural census. We also provide a list
of prospective candidates for crystallographic analyses,
with two priorities in mind: (i) maximization of structural
coverage (availability of structural templates for conﬁdent
modeling of a possibly largest number of sequences
signiﬁcantly related to these templates), and (ii) high-
resolution structural characterization of folds that are
either completely new or at least have not been reported
among Type II REases.
METHODS
Sequence analyses
Sequence searches of the nonredundant (nr) and environ-
mental samples (env_nr) database were carried out using
a locally installed version of PSI-BLAST (50). Gapped
blast algorithm (blastpgp) was used with default para-
meters [BLOSUM62 substitution matrix, gap open pen-
alty 11, gap extension penalty 1, without iterating and
with expectation (E) value threshold of 0.02].
To identify (sub)families of closely related sequences
and visualize similarities within and between all genuine
REases and their homologs we used CLANS (CLuster
ANalysis of Sequences), a Java utility based on the
Fruchterman-Reingold graph layout algorithm (51).
CLANS uses the P-values of high-scoring segment pairs
(HSPs) obtained from an N   N BLAST search, to com-
pute attractive and repulsive forces between each sequence
pair in a user-deﬁned dataset. A 3D or 2D representation
is achieved by randomly seeding sequences in the arbitrary
distance space. The sequences are then moved within this
environment according to the force vectors resulting from
all pairwise interactions and the process is repeated to
convergence.
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were extracted from the CLANS output and aligned using
MUSCLE (52). In cases of low sequence similarity,
alignments were also constructed with other programs,
MUMMALS (53), MAFFT (54) and PROBCONS (55),
and checked for consistency. Those sequences of REase
homologs, which could be aligned to true REases, but
exhibited deletions (>30% of the alignment missing) were
discarded. Manual adjustments were introduced into
the alignments to preserve the continuity of secondary
structure elements, either observed in crystal structures of
representative family members, or predicted computation-
ally (see below).
Domain assignment for proteins was performed mainly
by Conserved Domain Database search service (56) with
default parameters. Additional searches were made using
HHPRED (57) against the database of all available
sequence proﬁles. If a reliable multiple sequence alignment
for a given sequence was available (see above), it was used
as a query instead of a single sequence.
Structure prediction
Protein structure prediction was carried out using a new
version (http://genesilico.pl/meta2/) of the GeneSilico
MetaServer (58), which is a gateway for a variety of
methods for making predictions and analyzing their
results. For each REase subfamily, at least one represen-
tative sequence was submitted, and often additional
predictions were made for individual domains, other
members and whole alignments. Secondary structure
was predicted using a consensus of PSIPRED (59),
PROFsec (60), PROF (61), SABLE (62), JNET (63),
JUFO (64), PORTER (65), SSPRO2 (66) and SAM-T02
(67). Solvent accessibility for individual residues was
predicted with SABLE (62), ACCPRO2 (66) and JNET
(63). The fold-recognition (FR) analysis (attempt to
match the query sequence to known protein structures)
was carried out using a series of methods: PDB-BLAST
[local implementation of a PSI-BLAST (50) search
against sequences of proteins from PDB], HHSEARCH
(68), FORTE (69), SAM-T02 (67), 3DPSSM (70), INBGU
(71), FUGUE (72), mGENTHREADER (73) and
SPARKS (74). Target-template alignments reported
by these methods were compared, evaluated and ranked
by the PCONS server (75) to identify the preferred
template.
We have not attempted to build three-dimensional
models for all REases, as currently this analysis is too
demanding; it usually requires iterative comparative
modeling of the core and model evaluation often accom-
panied by de novo folding of variable parts, with a lot of
manual intervention and time-consuming calculations,
which can take weeks or even months per protein [see
previously published examples, e.g. (76)]. The alignments
published in this work, will however serve as a convenient
starting point for building complete models in the future,
when experimental data to directly test the models become
available, and it will be worthwhile to invest time and
computing power.
RESULTS
Identification of known andputative REases
We retrieved 1637 sequences of all Type II REases
(genuine and putative enzymes, including sequences
from metagenomics projects) from REBASE (edition 25
January 2008). For these sequences, we carried out pre-
liminary clustering with CLANS (51), to detect groups of
proteins exhibiting BLAST P-value <0.001 in pairwise
comparisons (see Methods section for details). The results
(data not shown) revealed four large clusters of 471, 221,
125 and 42 sequences, comprising all experimentally
characterized Type IIC enzymes (including Type IIG
and Type IIB) and their closest homologs, and a large
number of very small clusters and ORFans. By deﬁnition,
all known type IIC enzymes possess in the same
polypeptide a nuclease domain and a DNA:m
6A MTase
domain. While the nuclease domains exhibit relatively low
similarity (characteristic for REases of all types), the
MTase domains exhibit very high sequence conservation
(typical for MTases), leading all Type IIC enzymes to
cluster together—regardless of the presence or absence of
similarity between their non-MTase parts of the sequence.
Preliminary clustering revealed also several other smaller
clusters of proteins that shared sequence similarity in
various kind of non-nuclease domains (such as the GHKL
domain common to the ATPase/kinase superfamily (77)
or the DEXDc helicase domain), but no similarity in
known or predicted nuclease domains.
In order to cluster Type II REase sequences only with
respect to similarity of their nuclease domains, we decided
to identify all domains in sequences from REBASE
and create a set of sequences from which all conserved
non-nuclease domains have been deleted. This was made
by retrieving sequences from sequence clusters, making
multiple sequence alignments, assigning domains by
CDD and HHPRED (see Methods section), followed by
deletion of assigned non-nuclease domains. If necessary,
additional subclustering and domain assignment was done
for each cluster. We omitted very short sequences (<50aa,
e.g. from peptide sequencing), identical sequences and
those lacking nuclease domains (e.g. due to truncation);
this included partial sequences of some experimentally
characterized enzymes, e.g. Aor13HI or PvuI.
To identify additional homologs not present in
REBASE, we carried out BLAST searches of the nr
database and environmental samples database (env_nr)
using all Type II REase sequences (without conserved
non-nuclease domains). For all BLAST hits,
we performed domain assignment with the same proce-
dure as for sequences from REBASE. Likewise, non-
nuclease domains were identiﬁed and removed. As a
result, we obtained a set of 3132 sequences in two
categories: one comprising full-length sequences, and
the other with promiscuous domains removed (i.e.
REases comprising either exclusively nuclease domains,
or nuclease domains with extensions that did not exhibit
high similarity to domains in non-REase proteins). The
latter set will be referred to the ‘nuclease domain’ set for
simplicity.
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The nuclease domain dataset was clustered using CLANS
(Figure 1), which allowed us to classify all Type II REases
into 190 subfamilies that contain mutually related proteins
and ORFans that exhibit no easily detectable similarity of
nuclease domain to proteins from other subfamilies. The
distribution of size of these 190 subfamilies is shown in
Figure 2.
For all conﬁrmed and putative Type II REases in our
dataset, we carried out an extensive survey of the
published literature and databases to identify experimen-
tal data, structural predictions, sequence analyses and
phylogenetic studies. Our aim was to collect all experi-
mental data and reasonable predictions that could provide
hints to the structural and evolutionary classiﬁcation of
Type II REases, i.e. assignment of sequences to structural
folds, grouping of subfamilies into families and families
into superfamilies. We were able to identify published
crystallographic evidence for members of 23 subfamilies,
published structural prediction supported by experiment
(e.g. mutagenesis) for members of additional 20 subfami-
lies and published predictions that have so far not been
tested for additional 21 subfamilies. For 126 subfamilies
we could ﬁnd neither experimental data nor reliable
predictions, which made them priority targets for our
structure prediction methods. Based on analysis of all
types of data available as well as the results of our
preliminary sequence analyses, we named each subfamily
after one representative enzyme, which in our subjective
opinion was best studied from the structural or functional
point of view or which exhibited features that were most
typical for a given subfamily.
For 126 subfamilies that comprised structurally unchar-
acterized proteins and for any of the previously mentioned
subfamilies where we had any doubts about the correct-
ness of the published structural assignments, we carried
out structure prediction via the GeneSilico MetaServer
(58) using the protein Fold Recognition (FR) approach
(see Methods section). The interpretation of FR results
and selection of the best template was aided by analyzing
the patterns of residue conservation in the light of
Figure 1. Clustering of Type II REase sequences and their assignment to three-dimensional folds. (A) Representative structures of nuclease domains
of Type II REases or proteins sharing the same fold: PD-(D/E)XK: BamHI (3bam); the universally conserved core is indicated in green,
nonconserved structures in gray, HNH: catalytic domain of T4 endonuclease VII (1en7), PLD: catalytic domain of R.BﬁI (2c1l), GIY-YIG: catalytic
domain of homing endonuclease I-TevI (1mk0), HALFPIPE: R.PabI (2dvy). (B) Results of clustering of Type II REases from REBASE and their
homologs in the nr and env_nr database with CLANS (with promiscuous domains, such as MTase or GHKL domains, excluded from analysis).
Structures in (A) and sequences in (B) are colored according to the their assignment to fold families (see below): PD-D(E)XK: green, HNH: blue,
GIY-YIG: yellow, PLD: magenta, HALFPIPE: cyan, unclassiﬁed: red. Connections between dots represent the degree of pairwise sequence
similarity, as quantiﬁed by BLAST P-value (the darker the line, the higher similarity). The whole ‘galaxy’ of REases is held together by a certain level
of ‘background’ similarity between diﬀerent (often unrelated) sequences that is due to pure chance. Thus, while connections within dense clusters
practically always reﬂect high similarity and evolutionary relationship, connections between clusters do not have to reﬂect their phylogenetic
relationships (although they often do, especially in the case of close connections with multiple dark lines). All subfamilies with >20 members or with
representatives with solved X-ray structures have been labeled by the name of their representative sequence.
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family and in the putative templates. In a few particularly
diﬃcult cases the fold prediction was aided by building
three-dimensional models using the FRankenstein’s
Monster approach (78,79) and analysis of sequence–
structure compatibility in 3D using a series of Model
Quality Assessment Programs (80) (see Methods section
for details). The FR analysis allowed us to predict 3D
folds and identify putative homology between Type II
REase subfamilies and proteins of known structure,
including all previously solved structures of Type II
REases and their homologs. We have also used
HHSEARCH (68) to perform a series of pairwise
proﬁle-to-proﬁle comparisons for all alignments of sub-
families represented as proﬁle hidden Markov models
(HMMs) that include information both about sequence
conservation (if more than one sequence is available) and
secondary structure predicted by PSIPRED (59). This type
of analysis allowed us to identify putative homology
between diﬀerent Type II REase subfamilies, including
those for which no experimental structural information
is available. Combination of structure and sequence-
oriented searches allowed us to make fold predictions
based on the principle of transitivity of homology. For
example if subfamily A was found to be homologous to
subfamily B, and the same sequence region in subfamily B
that was matched with subfamily A was also found to
match a structure of a known fold characteristic for
subfamily C, then subfamily A was predicted to be homo-
logous to subfamily C regardless of the absence of a direct
match.
As a result of the aforementioned analyses, we
conﬁrmed all previously reported 3D fold predictions,
and made new predictions for 52 subfamilies. Thus, as a
result of our survey, we assigned three-dimensional folds
to 1528 Type II REase sequences and their homologs
based on previously published analyses and our align-
ments, and we made new predictions about the fold and
active site for 1027 Type II REase sequences and their
homologs. For 577 Type II REase sequences and their
homologs (i.e. 18.4% of all sequences; 73 subfamilies
among 190 subfamilies total), we could not make any
structural assignment, based either on literature and
database searches or on our new bioinformatic analyses.
The results of our survey are summarized in Table 1.
Sequence alignments of core residues for representatives
of all ‘assignable’ subfamilies are shown in Figure 3
[PD-(D/E)XK superfamily, 98 or 51.6% subfamilies],
Figure 4 (HNH superfamily, 14 or 7.4% subfamilies),
Figure 5 (PLD superfamily, 2 or 1.1% subfamilies) and
Figure 6 (GIY-YIG superfamily, 2 or 1.1% subfamiles).
We found no new subfamilies from the HALFPIPE
superfamily compared to the previously published study,
therefore readers are referred to the original publication
for comparative analysis (40,81).
Analysisof domain architectures
3D fold assignment of nuclease domains together with
assignment of non-nuclease domains enabled us to study
the diversity of domain organization of conﬁrmed and
putative Type II REases. We found out that REases show
great variety of possible compositions as we observed 50
diﬀerent types of domain fusions and rearrangements
(Figure 7). The most frequently found domains in REases
(apart from nuclease domains) are: MTase domains,
variants of helix–turn–helix (HTH) DNA-binding
domains (e.g. ‘winged helix’, wH) and diﬀerent kinds of
domains associated with helicase or ATPase functions
(DEXD-box, GHKL). Interestingly, in seven subfamilies
(e.g.: R.MboI, R.SdaI) MTase domains are present only
in one or a few members. This observation suggests that
translational fusions of REase and MTase domains
occurred independently multiple times in the evolution,
and has been facilitated by the frequent occurrence of
REase and MTase domains in operons (i.e. transcriptional
fusions).
Figure 2. The distribution of size (number of members) among REase subfamilies. Seventy-seven subfamilies (41% of all subfamilies) contain
<5 sequences, which makes it very diﬃcult to analyze the patterns of sequence conservation and e.g. identify invariant residues that could form
active sites.
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Family name Number of
members
Type of evidence Reference Subtype Reliability
A) PD-(D/E)XK superfamily
EcoRI 14 X-ray EcoRI (14) P 4
EcoRV 14 X-ray EcoRV (15) P 4
PvuII 5 X-ray PvuII (90) P 4
BamHI 5 X-ray BamHI (91) P 4
Cfr10I 6 X-ray Cfr10I (26) P,F 4
BglI 17 X-ray BglI (31) P,F 4
FokI 9 X-ray FokI (92) S 4
MunI 6 X-ray MunI (93) P 4
BglII 17 X-ray BglII (94) P 4
NgoMIV 11 X-ray NgoMIV (95) F,P 4
NaeI 7 X-ray NaeI (96) E 4
BsoBI 8 X-ray BsoBI (25) P 4
EcoRII 45 X-ray EcoRII (97) P,E 4
MspI 4 X-ray MspI (98) P 4
MlyI 45 X-ray N.BspD6I (99) S,P 4
EcoO109I 10 X-ray EcoO109I (100) P 4
HinP1I 6 X-ray HinP1I (88) P 4
SdaI 43 X-ray SdaI (28) P 4
HincII 5 X-ray HincII (101) P 4
MvaI 36 X-ray MvaI (76,102) P 4




BcgI 31 Mutagenesis BcgI (103) C 3
TaqI 6 Mutagenesis TaqI (104) P 3
HindIII 11 Mutagenesis HindIII (105) P 3
Eco57I 37 Mutagenesis Eco57I (106) C 3
MboI 40 Mutagenesis MboI (43) P 3
Bsp6I 15 Mutagenesis Bsp6I (47) P 3
NlaIV 10 Mutagenesis, CD NlaIV (46) P 3
Mva1269I 3 Mutagenesis Mva1269I (45) S 3
HpaI 1 Mutagenesis HpaI (48) P 3
BpuJI 73 Mutagenesis BpuJI (107) S 3
BtsIA 1 Mutagenesis BtsIA (108) S 3
BtsIB 1 Mutagenesis BtsIB (108) S 3
R2.BsrDI 3 Mutagenesis R2.BsrDI (108) S 3
R1.BsrDI 2 Mutagenesis R1.BsrDI (108) S 3





XbaI 15 Sequence analysis (109) P 2
SalI 15 Sequence analysis (109) P 2
XmaI 9 Sequence analysis (110) E,P 2
Bpu10IB 18 Sequence analysis (111) S,P 2
DdeI 5 Sequence analysis (111) P 2
PvuRts1 46 Sequence analysis (22,34) ? 2
BanI 8 Sequence analysis (22,112) P 2
LlaBIII 152 Sequence analysis (113) C 2
Sau3AI 36 Sequence analysis (22,114) E,P 2
HaeIV 20 Sequence analysis (115) C 2
MjaI 6 Sequence analysis (22) P 2
ApaLI 1 Sequence analysis (22) P 2
Kpn2I 7 Sequence analysis (27) P 2
R2.LlaJI 16 Sequence analysis (116) P 2
ScrFI 13 Sequence analysis (76) P 2
TerMcrCP 112 Sequence analysis This work ? 2
CstMI 76 Sequence analysis This work C 2
TaqII 35 Sequence analysis This work C,S 2
HgiEI 25 Sequence analysis This work P 2
Hpy8I 20 Sequence analysis This work P 2
VeiORF1182P 19 Sequence analysis This work P 2
AvaII 18 Sequence analysis This work P 2
XhoI 16 Sequence analysis This work P 2
Hpy99II 16 Sequence analysis This work P 2
VeiORF1308P 14 Sequence analysis This work C 2
(continued)
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Family name Number of
members
Type of evidence Reference Subtype Reliability
Sho27844P 14 Sequence analysis This work S 2
Sau96I 13 Sequence analysis This work P 2
NspV 12 Sequence analysis This work P 2
McaTI 11 Sequence analysis This work P 2
Hpy99VIIIP 10 Sequence analysis This work P 2
MseI 9 Sequence analysis This work P 2
SuaI 6 Sequence analysis This work P 2
HpyCH4V 5 Sequence analysis This work P 2
SnaBI 5 Sequence analysis This work P 2
AboORF2079P 4 Sequence analysis This work P 2
MjaV 4 Sequence analysis This work P 2
Hpy99IV 4 Sequence analysis This work P 2
HpyHORF1023P 4 Sequence analysis This work P 2
DolHORF3097P 4 Sequence analysis This work ? 2
ThaI 3 Sequence analysis This work P 2
HhaII 2 Sequence analysis This work P 2
TﬁI 1 Sequence analysis This work P 2
Sse9I 1 Sequence analysis This work P 2
BssSI 1 Sequence analysis This work S 1
NmeDIP 46 Sequence analysis This work ? 1
CthORFS34P 30 Sequence analysis This work P 1
RsaI 11 Sequence analysis This work P 1
CviAI 9 Sequence analysis This work P 1
SmaI 8 Sequence analysis This work P 1
LlaDI 7 Sequence analysis This work P 1
HpyAIV 6 Sequence analysis This work P 1
HpyAORF483P 4 Sequence analysis This work P 1
RdepTB3ORF14P 4 Sequence analysis This work P 1
AgeI 4 Sequence analysis This work P 1
SacI 3 Sequence analysis This work P 1
MspA1I 3 Sequence analysis This work P 1
Mae7806ORF3417P 3 Sequence analysis This work P 1
PhoI 2 Sequence analysis This work P 1
AvaBORF4359P 2 Sequence analysis This work P 1
CfrBI 2 Sequence analysis This work P 1
MjaIV 1 Sequence analysis This work P 1
HinfI 1 Sequence analysis This work P 1
B) HNH superfamily
KpnI 2 Mutagenesis (37) P 3
MnlI 117 Mutagenesis (44) S 3
HphI 282 Mutagenesis (49) S 3
Eco31I 11 Mutagenesis (117) S 3
NlaIII 82 Sequence analysis (34,35) P 2
MboII 7 Sequence analysis (34,35) S 2
SapI 4 Sequence analysis (34,35) S 2
SphI 4 Sequence analysis (34,35) P 2
NspI 5 Sequence analysis (35) P 2
Hin4II 12 Sequence analysis (41) S 2
LcaA2P 229 Sequence analysis This work ? 2
Hpy99I 121 Sequence analysis This work P 2
Mae7806ORF5066P 13 Sequence analysis This work P 2
PacI 4 Sequence analysis This work P 1
C) PLD superfamily
BﬁI 3 X-ray BﬁI (36) S 4
NgoAVII 50 Sequence analysis This work P 2
D) GIY-YIG superfamily
Eco29kI 10 Mutagenesis Eco29kI (38) P 3







PabI 8 X-ray PabI (40) P 4
(continued)
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Although a complete description of all new fold assign-
ments and all domain organizations is beyond the limits of
a single publication, we would like to describe in more
detail the most interesting or most intriguing (in afew cases
potentially controversial) new ﬁndings and predictions:
R.LlaBIIP: this long protein (1461aa) appears to be a
fusion of HsdR-like and HsdM-like subunits, comprising
the putative ATP-dependent translocase and MTase
modules. However, the N-terminal region appears to lack
the PD-D(E)XK domain common to HsdR subunits.
Instead, the N-terminus contains a putative helical domain
HEPN found in nucleotidyltransferases (aa 1–130), and
another putative domain (aa 130–250), which shows no
sequence or secondary structure similarity to any known
nuclease domains. It would be very interesting to test
experimentally whether R.LlaBIIP (and in particular its
unusual N-terminal region) exhibits a nuclease activity.
R.CviAI (GATC speciﬁc) (82) is predicted to be a
PD-(D/E)XK superfamily member, yet it shows no
obvious similarity to other GATC-speciﬁc enzymes (e.g.
neither the R.MboI nor the R.Sau3AI subfamily). Thus,
we predict that its substrate speciﬁcity represents a case of
convergent evolution within the same structural scaﬀold,
used multiple times to independently develop recognition
of the same DNA sequence.
R.HgiDII contains two domains. As mentioned earlier,
the N-terminal domain belongs to the GHKL superfamily,
which includes e.g. the MutL enzyme involved in DNA
mismatch repair [where MutH is the associated nuclease
from the PD-(D/E)XK superfamily]. The C-terminal
Table 1. Continued




LlaBIIP 66 C –
XcaVORF2165P 52 C –
AnipAL1ORF76P 46 C –
NspJCORF4770P 42 C –
AauTCORF286P 23 C –
HpaII 24 P,E –
CglORF706P 21 C –
DpnI 20 M –
MteORF2238BP 18 C –
Fsp4HI 18 P –
NmeAIP 18 P –
BseRI 17 C,S –
BtlORF114P 17 C –
BweKORF2188P 13 P –
EcoUTORF4938P 12 P –
HaeII 11 P –
MgiORF5513P 11 C –
CviJI 10 P –
HgiDI 10 P –
AvaIII 9 P –
TerORF950P 8 ? –
RshI 6 P –
ApeKI 6 P –
LlaBI 6 P –
XmnI 6 P –
HaeIII 5 P –
BstXI 5 P –
SuaMcrB2P 5 ? –
AccI 5 P –
LxxORF2510P 5 ? –
LweSORF291P 4 P –
HgaI 4 S –
BhaI 4 S –
CglP6P 3 P –
NheI 2 P –
GviORF2740P 2 C –
NcoI 2 P –
CviAII 2 P –
AluI 2 P –
Rca13841ORF3082P 2 C –
AatII 2 P –
TspMI 2 P –
LlaIA 1 ? –
Lmo19115ORF1P 1 ? –
RspRSORF4066P 1 P –
BsuMIA 1 P –
EsaSS1430P 1 C –
BssHII 1 P –
EsaNPORF9P 1 S –
TspRI 1 P –
BalI 1 P –
AhdI 1 P –
BsuRI 1 P –
EsaSS157P 1 ? –
CviQI 1 P –
BlopNAC1P 1 P –
BslIA 1 P –
SspI 1 P –
SonORF4P 1 P –
BsrGI 1 P –
BslIB 1 P –
GurRORF3275P 1 P –
FpsJIPORF858P 1 P –
HgiDII 1 P –
BseMII 1 S –
BspLU11III 1 C,S –
(continued)
Table 1. Continued
Family name Number of
members
Subtype Reliability
CwaWHORF3980P 1 ? –
HauORF1126P 1 P –
Mae7806ORF1639AP 1 C –
PcaJCMORF748P 1 C –
PmoSJORF1273P 1 C –
UmeRCIORF389P 1 C –
TmaI 1 P –
Families are named after the subjectively chosen most representative
and/or best studied candidate. The number of members and subtypes of
its members (according to REBASE, ‘?’ means no subtype information
present) are indicated. The description of subtypes can be found in
ref. (1). Very brieﬂy, P indicates orthodox dimeric enzymes that
recognize a single palindromic site, S indicates enzymes that cut at a
ﬁxed distance from an asymmetric site, E indicates enzymes that require
an additional eﬀector site, F indicates tetrameric enzymes that cut two
sites, C indicates enzymes comprising REase and MTase activities in
the same polypeptide and M indicates enzymes that cleave modiﬁed
DNA. The type of evidence supporting the assignment is described,
including the type of analysis and references to the key publication(s).
Our subjective assessment of the conﬁdence level for diﬀerent 3D-fold
assignments is indicated: 4 indicates certain, high-resolution experi-
mental information (e.g. from crystallography), 3 indicates prediction
supported by low-resolution experimental data (e.g. mutagenesis),
2 indicates conﬁdent, but purely theoretical prediction that remains
to be tested experimentally, 1 indicates purely theoretical prediction
with some level of uncertainty (e.g. poor scores, problems with
identiﬁcation of a full set of catalytic residues based on the model etc.).
3560 Nucleic Acids Research, 2008, Vol. 36, No. 11Figure 3. Sequence alignment of representative Type II REases from all subfamilies of the PD-(D/E)XK superfamily. Sequences of REases are
preceded with sequences of several proteins from this superfamily with solved crystal structures and with typical secondary structure representation
(of 1gef Holiday junction resolvase). Amino acids are colored according to physico-chemical properties of their side chains (negatively charged: red;
positively charged: blue, violet; hydrophilic: gray; hydrophobic: green, magenta, yellow). Residues with more than 50% sequence conservation are
shaded. Nonconserved sequence linkers between conserved blocks have been omitted for clarity.
Nucleic Acids Research, 2008, Vol. 36, No. 11 3561domain of R.HgiDII remains unassigned to any of
the known REase folds, or in fact to any known fold
or protein family. Interestingly, among four other
subfamilies of REases that exhibit the GHKL domain
in the N-terminus, one (R.VeiORF1182P) contains the
C-terminal domain of the PD-(D/E)XK fold, and in
three others (R.NmeAIP, R.EcoUTORF4938P and
R.LweSORF291P) the C-terminal extension is apparently
diﬀerent from that in either R.HgiDII or R.VeiORF1182P.
The C-terminal domain of R.NmeAIP shows signiﬁcant
similarity to an uncharacterized protein family dubbed
‘Hypoth_Ymh’ in PFAM (CDD search e-value 3e-22). On
the other hand, the C-terminus of R.EcoUTORF4938P
exhibits similarity to a signal transduction histidine kinase
domain from the GHKL superfamily (CDD search e-value
3e-8) with conserved N, D, F and G motifs required for the
catalytic activity (83). However, middle parts of both
R.NmeAIP and R.EcoUTORF4938P remain unassigned
to any known protein family and may contain additional
domains. It will be very interesting to determine experi-
mentally the role of the unassigned domains in GHKL-
containing REases, and if they turn out to be responsible
for the REase activity, they would constitute interesting
candidates for new folds (and thereby, for structure
determination by X-ray crystallography).
R.DpnI is a representative of a large family of REases
that cleave GATC sequence only if the adenosine is
methylated to m
6A. We identiﬁed a putative Zn-binding
region in the N-terminal part of their sequences
(a conserved tetrad of Cys residues), but thus far we
failed to determine its relationship to any known protein
family or any known protein structure. Thus, we propose
R.DpnI as an attractive target for structure determination
by X-ray crystallography.
R.HphI: the analysis of this subfamily has been
published (49), but we believe it is worth re-emphasizing
Figure 4. Sequence alignment of representative Type II REases from all subfamilies of the HNH superfamily. Sequences of REases are preceded with
sequences of several proteins from this superfamily with solved crystal structures and with typical secondary structure representation (of 1en7 T4
endonuclease VII). Amino acids are colored according to physico-chemical properties of their side chains (negatively charged: red; positively charged:
blue, violet; hydrophilic: gray; hydrophobic: green, magenta, yellow). Residues with more than 50% sequence conservation are shaded.
Figure 6. Sequence alignment of representative Type II REases from the GIY-YIG superfamily. Sequences of two REases are preceded by sequences
of GIY-YIG members with solved crystal structures and with the secondary structure of I-TevI homing endonuclease (1mk0). Amino acids are
colored according to physico-chemical properties of their side chains (negatively charged: red; positively charged: blue, violet; hydrophilic: gray;
hydrophobic: green, magenta, yellow). Residues with more than 70% sequence conservation are shaded. Nonconserved sequence linkers between
conserved blocks have been omitted for clarity.
Figure 5. Sequence alignment of representative Type II REases from the PLD superfamily. Sequences of REases are preceded with a sequence of
Nuc nuclease (1BYR) from the PLD superfamily and with the secondary structure of R.BﬁI (2c1l). Amino acids are colored according to physico-
chemical properties of their side chains (negatively charged: red; positively charged: blue, violet; hydrophilic: gray; hydrophobic: green, magenta,
yellow). Residues with more than 70% sequence conservation are shaded.
3562 Nucleic Acids Research, 2008, Vol. 36, No. 11that many members of this subfamily are most likely not
Type II REases, as they lack MTase neighbors. Thus, it
has been predicted that they might belong to another
category of selﬁsh nucleases, perhaps similar to homing
endonucleases (HEases).
R.LcaA2P is a very close relative of HEases I-HmuI,
I-HmuII and I-BsoI that act as nicking enzymes (BLAST
e-value: 6e-11 with I-HmuI). Many other members of the
LcaA2P family are therefore most likely HEases rather
than Type II REases. On the other hand, it will be very
interesting to determine whether R.LcaA2P is functional,
and if it is—whether it acts as a nicking enzyme or as a
‘normal’ dsDNA nuclease and whether its activity can be
inhibited by DNA methylation by the putative MTase
encoded by the neighboring gene (M.LcaA2P). Should
cleavage by LcaA2P be prevented by methylation, this
enzyme may be considered an evolutionary intermediate
between REases and HEases.
R.NgoAVIIP: sequences from this subfamily are con-
ﬁdently predicted to belong to the PLD superfamily, based
on results of both FR and HHSEARCH analyses (e.g.
FFAS score—23.9 to R.BﬁI REase, HHSEARCH e-value
1.9e-14 to the proﬁle of the R.BﬁI subfamily). Moreover,
analysis of the multiple sequence alignment reveals that
putative catalytic residues are present. However, thus far
eﬀorts to detect the nuclease activity of R.NgoAVIIP
have remained unsuccessful (V. Siksnys, IBT Vilnius,
Lithuania, personal communication). Interestingly, the
C-terminal domain of R.NgoAVIIP shows signiﬁcant
similarity (HHPRED e-value 7e-19) to the C-terminal
domain of proteins from another nuclease subfamily
(R.Fsp4HI), but they do not seem to share any detectable
similarity in the catalytic domain. Thus far, we were
unable to identify a known nuclease domain in R.Fsp4HI
therefore we propose it as an interesting candidate for
further experimental analysis. It would be worthwhile to
Figure 7. A variety of primary structures (domain architectures on the sequence level) in conﬁrmed and putative Type II REases. Sequences are
aligned by their nuclease domains. Drawing in scale, length of PD-D(E)XK domain corresponds to 110aa. Some very long sequences are broken for
the clarity of presentation.
Nucleic Acids Research, 2008, Vol. 36, No. 11 3563identify catalytic residues in this nuclease and to check
whether its mode of action resembles other REases or
other enzymes from the PLD family.
Hypothetical protein SAV_2336 (gi:29828878): this very
long protein (1667aa) from Streptomyces avermitilis
shows clear similarity to R.NaeI enzyme from the PD-
D(E)XK superfamily in its C-terminus (aa 1359-1657
BLAST e-value 2e-28, alignment spanning the catalytic
domain and the wH DNA-binding domain, suggesting
that SAV_2336 binds two copies of the target DNA
sequence, like R.NaeI). The N-terminal part of SAV_2336
sequence shows signiﬁcant similarity to the VWA-type
domain of unknown function from CO-oxidizing operons
in bacteria (HHPRED e-value 1e-06). The central part of
SAV_2336 is related to ATPase domains from the MalT
family of transcription regulators (e-value <1e-06). This
combination of multiple domains that may be involved
not only in restriction, but also other aspects of nucleic
acid metabolism, makes SAV_2336 an attractive target for
experimental analyses.
R.PhoI shows remote similarity to archaeal Holliday
junction resolvases from the PD-(D/E)XK superfamily
(HHSEARCH hit to PFAM proﬁle for archaeal Holliday
junction resolvases Hjc with probability 58.4%) and an
expected pattern of secondary structures associated with
the catalytic core. However, its catalytic residues appear to
be missing, as the PD-(D/E)XK motif is replaced by a
PI-ERL variant. One possible explanation is that this
protein exhibits an extreme case of catalytic residue
migration to alternative locations in protein structure, as
described earlier individually for the (D/E) residue in
R.Cfr10I (84) and for the K residue in putative cyano-
bacterial nucleases (29) and in the R.SdaI subfamily (28).
However, we found only one close homolog of R.PhoI,
which provided insuﬃcient information to predict cata-
lytic residues based on residue conservation, and the
preliminary model (data not shown) revealed no good
candidates for a spatially reorganized active site. Thus, if
R.PhoI is indeed active as a REase and if our 3D fold
prediction is correct, it will be very interesting to deter-
mine its exact mode of action in vitro, especially its ability
to catalyze the phosphodiester bond hydrolysis.
Some catalytically inactive mutants of Type IV REase
McrA have been shown to restrict phage growth in vivo,
presumably due to unproductive site-speciﬁc binding of
the protein to a phage DNA, which could disrupt the
phage development program at an early stage (85). It
will be interesting to determine if REases, such as
R.NgoAVIIP and perhaps also R.PhoI, that may be
inactive as nucleases, can nevertheless function as REases
in vivo, and if this activity can be inhibited by site-speciﬁc
methylation by the cognate MTase.
Putative REases from the MjaORF1200P subfamily
(four sequences in the REBASE set) are most likely RNA
MTases rather than REases. According to the fold-
recognition analysis [recently published as a separate
article (86)], these proteins show clear similarity to the
SPOUT superfamily of RNA MTases, and they exhibit no
additional domains or residues that would suggest them to
act as REases. We suspect that they were (most likely
incorrectly) assigned as Type II REases due to the
genomic association of MjaORF1200P (ORF MJ1199)
with a putative DNA:m
5C MTase (M.MjaORF1200P).
Putative REases from the BceAUORF42P subfamily
(three sequences in the REBASE set) are most likely Type
III rather than Type II REases. In database searches they
show clear similarity to Type III Res subunits and they are
genetically associated with homologs of Type III MTase
subunits.
R.SauN315ORF189P: members of this family show
signiﬁcant sequence similarity and similar domain orga-
nization to Type I REase HsdR proteins [e.g. e-value
3.5e-47 for a HHSEARCH alignment with the N terminus
of R subunit of Type I restriction enzyme (HSDR_N)
proﬁle from the PFAM database].
R.EcoCH14P: sequence of this short protein (95aa) is
similar (HHPRED E-value 4e-05) to a C-terminal helical
domain found in Type I REase HsdR proteins and
implicated in binding to the Type I MTase complex rather
than in the nuclease activity.
Distribution of 3D folds among confirmed and putative
REases. From the aforementioned examples it is quite
clear that the correctness of our estimated 3D fold
distribution among REases is inﬂuenced not only by the
quality of bioinformatic methods and the conﬁdence in
individual predictions or the availability of experimental
data to support structural predictions, but also by the
conﬁdence in assignment of a given protein as a REase
candidate. In particular, our analysis revealed a number
of protein families comprising REases, in which some
(or even most) members are most likely not REases, but
fulﬁll some other function. Therefore, it is interesting to
compare the distribution of 3D fold assignments in sets of
experimentally validated Type II REases versus the
expanded dataset comprising also putative enzymes.
To this end, we divided all sequences of Type II REases
and their homologs into classes on the basis of their
source:
(1) CONFIRMED set: all sequences from REBASE
with nuclease activity conﬁrmed experimentally;
(2) PREDICTED set: sequences from REBASE without
direct experimental conﬁrmation, excluding the data
from environmental DNA sequencing projects;
(3) NR set: homologs of sequences from sets 1–2 that
are not present in REBASE, but were identiﬁed by
us in the nr database at the NCBI; and
(4) ENV set: putative REases in REBASE predicted from
environmental DNA sequencing projects and identi-
ﬁed by us in the environmental samples database
(env_nr).
For each of these classes, we additionally created a
‘purged’ variant, from which we removed sequences above
the level of 90% sequence identity. We used the following
hierarchy of importance (from the most important to the
least important): CONFIRMED set > PREDICTED set
> NR set > ENV set. Thus, we removed all sequences
from environmental samples not present in REBASE that
exhibited  90% sequence identity to any of the sequences
from ‘higher classes’, then the same was applied to all
3564 Nucleic Acids Research, 2008, Vol. 36, No. 11putative REases from nr and so on. Finally, if several
genuine REases exhibited  90% sequence identity to each
other, only one of them was retained. We have also
considered an additional PUTATIVE set, which is a sum
of PREDICTED, NR and ENV sets, thus contains all
sequences that have NOT been experimentally conﬁrmed
to function as REases. Table 2 shows the number of
sequences present in each of the original and purged
datasets and in each fold. The fractions of enzymes
assigned to diﬀerent folds for the CONFIRMED set,
PREDICTED set and for the PUTATIVE set, purged at
maximum 90% identity, are shown in Figure 8.
In all datasets analyzed in this work, the largest number
of structurally classiﬁable enzymes always belong to
PD-(D/E)XK superfamily. PD-D(E)XK family is over-
represented in the CONFIRMED set (68%) compared to
PREDICTED and PUTATIVE sets (60 and 48%,
respectively). This is caused by the fact that this family
is the most intensively studied [e.g. almost all enzymes
with structures solved by X-ray crystallography belong to
the PD-(D/E)XK fold]. On the contrary, HNH super-
family, the second largest in all datasets, is overrepre-
sented in the PUTATIVE set (30%) compared to the
CONFIRMED and PREDICTED sets (9 and 8%,
respectively). As mentioned earlier, this might be due to
the fact that some of the genuine REases from the HNH
superfamily (e.g. R.HphI) exhibit similarity to putative
nucleases that are in fact unlikely to function as REases,
thus distorting the PUTATIVE set by inclusion of
potential false positives. In the case of R.HphI family,
only 20% of R.HphI homologs had detectable MTase
neighbors within 5000bp (49). On the other hand,
virtually all experimentally characterized, ‘orthodox’
Type II REases encoded in completely sequenced gen-
omes, whose sequences are available in REBASE
(including all experimentally characterized members of
the R.HphI family) do possess a MTase neighbor (8).
Distribution of DNA cleavage preferences among folds of
REases. An interesting question to be asked is whether
REases from particular folds exhibit preferences for
certain DNA sequences and/or cleavage patterns (length
of 30 or 50 overhangs). Should that be the case, the
experimental characterization of products of cleavage
could aid the prediction of folds (structure) or vice versa.
To answer this question, we have manually aligned DNA
recognition sequences for all type II REases from the
‘CONFIRMED’ set (see Supplementary Table 1). The
features of DNA sequences taken into account were, in
order of importance: the cleavage pattern (in some cases
with a tolerance of up to 1bp), the distance between
recognition site and cleavage site, the site of methylation
by a cognate MTase (if known) and the DNA sequence.
We also made a histogram of cleavage patterns for REases
from diﬀerent folds (Figure 9). It shows that the preferred
cleavage patterns are indeed diﬀerent for REases from
diﬀerent folds. REases from the PD-(D/E)XK family
show high preference for 50 overhangs or blunt ends, while
REases from the HNH superfamily prefer to generate 1-nt
or 4-nt 30 ends or 4-nt 50 ends. Interestingly, in our dataset
Table 2. Number of endonucleases exhibiting diﬀerent folds and diﬀerent sources
SET\Family PD-(D/E)XK GIY-YIG PLD HALFPIPE HNH Unclassiﬁed Sum
CONFIRMED 199 (173) 6 (4) 3 (3) 1 (1) 24 (24) 56 (51) 289 (256)
PREDICTED 460 (357) 7 (3) 9 (8) 0 (0) 112 (45) 203 (178) 791 (591)
NR 401 (358) 3 (3) 17 (15) 7 (4) 359 (322) 137 (121) 924 (823)
ENV 508 (482) 17 (17) 24 (23) 0 (0) 398 (372) 181 (174) 1128 (1068)
PUTATIVE (PREDICTED+NR+ENV) 1369 (1197) 27 (23) 50 (46) 7 (4) 869 (739) 521 (473) 2843 (2482)
ALL (CONFIRMED+PUTATIVE) 1568 (1370) 33 (27) 53 (49) 8 (5) 893 (763) 577 (524) 3132 (2738)
CONFIRMED, all sequences from REBASE with nuclease activity conﬁrmed experimentally; PREDICTED, sequences from REBASE without direct
experimental conﬁrmation, excluding the data from environmental DNA sequencing projects; NR, homologs of sequences from sets CONFIRMED and
PREDICTED that are not present in REBASE, but were identiﬁed by us in the non-redundant (nr) database at the NCBI; ENV, Putative REases from
environmental DNA sequencing projects, predicted by REBASE or by us in env_nr database. PUTATIVE=PREDICTED+NR+ENV. Values in
parentheses correspond to the number of sequences with no more than 90% sequence identity.
Figure 8. Fraction of enzymes assigned to diﬀerent folds, purged at maximum 90% identity. (A) Conﬁrmed REases from REBASE; (B) putative
REASES from REBASE; (C) putative REASES from REBASE and all homologs found nonredundant (nr) and environmental samples (env_nr)
NCBI database.
Nucleic Acids Research, 2008, Vol. 36, No. 11 3565there is not a single case of REases with the same
recognition sequence and cleavage pattern that would
have diﬀerent folds, while the probability of such situation
in case of random distribution of known cleavage patterns
to Type II REases from diﬀerent families is <10
 6 (data
not shown). This ﬁnding suggests that the knowledge of
the target sequence and cleavage pattern could be used as
a predictor for the 3D fold assignment. Interestingly, one
of the enzymes for which we failed to predict the structure
using bioinformatic methods, i.e. R.HpaII (87), cleaves
the same DNA sequence (C0CG,G) as another enzyme of
known structure, namely R.HinP1I from the PD-(D/
E)XK superfamily (88). Neither secondary structure
prediction nor ‘sequence gazing’ allowed us to propose
any reliable candidate of the PD-(D/E)XK motif in
R.HpaII, therefore we propose it as a valuable target for
experimental structure determination by X-ray
crystallography.
CONCLUSIONS
The results of our bioinformatics analysis provide the very
ﬁrst classiﬁcation of all Type II REase sequences into
families and superfamilies, and a comprehensive structural
census. We believe that our results will be very useful for
experimental researchers. First, a number of particularly
interesting candidates for crystallographic analyses are
proposed, with two priorities in mind: (i) high-resolution
structural characterization of folds that are either com-
pletely new or at least have not been reported among Type
II REases, and (ii) maximization of structural coverage
(availability of structural templates for conﬁdent modeling
of a possibly largest number of sequences signiﬁcantly
related to these templates). Second, our delineation of
sequence-related groups of REases that exhibit diﬀerences
in substrate speciﬁcity suggests that detailed comparative
analyses (that are beyond the scope of this article) could
provide insight into the molecular basis of diﬀerent
speciﬁcity. Such groups of nucleases appear to require a
smaller number of mutations to change the substrate
preference and therefore they may be particularly useful
targets for experimental protein engineering aiming at
development of enzymes with new speciﬁcities. Finally,
the observed correlation between the structural folds and
the patterns of cleavage (length of ends) provides evidence
to support the earlier prediction that the phenotypes of
REases may correlate with their evolutionary relation-
ships (89). Thus, structural predictions for putative
REases (e.g. those identiﬁed by genome sequencing) may
aid in prediction of their cleavage patterns and thereby
simplify the planning of experiments to characterize them
functionally. Conversely, functional characterization of
enzymes with unknown structure may provide hints as to
their 3D folds. Indeed, the recently characterized REase
R.PabI with unusual DNA recognition sequence and
cleavage pattern (39) turned out to exhibit a completely
new type of structure. Although these correlations should
by no means be taken as a rule, they may help experi-
mentalists in prioritization of experiments, aiming at
identiﬁcation and characterization of proteins with
particular features of interest.
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